Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Future CAGR of the Small Molecule Drug Discovery Market, and How Will It Impact Industry Expansion?

Over the past few years, the size of the small molecule drug discovery market has seen considerable growth. The market, which is projected to increase from $62.44 billion in 2024 to $68.57 billion in 2025, will experience an annual compounded growth rate (CAGR) of 9.8%. Various factors such as initiatives to repurpose drugs, automation in drug discoveries, an increased input in research and development, regulatory support towards drug innovation, and enhancements in high-throughput screening have all contributed to the historic growth in this field.

In the coming years, the market size for small molecule drug discovery is expected to expand rapidly, reaching a staggering $106.91 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 11.7%. The expected growth in this period is due in part to the identification of novel therapeutic targets, the development of drugs catered to specific patient needs, the combination of drugs and devices, the use of real-world evidence, the integration of pharmacogenomics, and ongoing global health issues. Prominent trends projected for this period include fragment-based drug discovery, the use of artificial intelligence in drug discovery, therapeutics focused on RNA-targets, increased collaborations and partnerships, innovative drug delivery methods, and the adoption of organoids and 3D cell culture models.

Which Drivers Are Expected to Have the Greatest Impact on the small molecule drug discovery Market’s Growth?

The small molecule drug discovery market stands to benefit from the increasing prevalence of chronic illnesses. Chronic diseases are those that persist for over a year or longer, impeding daily activities and requiring ongoing medical intervention or both. Conditions such as HIV, cancer, infections, heart disease, and kidney disease can be managed with small-molecule medications, which are typically more cost-effective for patients suffering from long-term diseases. Consequently, the small molecule drug discovery market is poised for growth due to the rising instances of chronic diseases. To illustrate, research from the National Institutes of Health (NIH), a United States’ biomedical research agency, predicts that by 2023, the number of US residents aged 50 and above with at least one chronic disease is expected to surge by 99.5%, moving from 71.522 million in 2020 to 142.66 million in 2050. The population with multiple conditions is also anticipated to increase by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Hence, the increasing occurrence of chronic disease is spurring the expansion of the small molecule drug discovery market.

Get Your Free Sample of the Global Small Molecule Drug Discovery Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

What Are the Top Market Players Propelling the Growth of the Small Molecule Drug Discovery Industry?

Major companies operating in the small molecule drug discovery market include:

• Pfizer Inc._x000D_

• GlaxoSmithKline plc_x000D_

• AstraZeneca_x000D_

• Boehringer Ingelheim International GmbH_x000D_

• Bristol-Myers Squibb Company_x000D_

What Are the Key Trends to Watch in the Small Molecule Drug Discovery Market Over the Coming Years?

A rising trend in the small molecule drug discovery market is the focus on technological advancements. Many leading companies in this field are channelling their efforts towards new product development. For example, Dotmatics, an American digital science platform provider, launched the Small Molecule Drug Discovery Solution in January 2023. This solution is distinctively designed with a pre-configured scientific R&D platform and enriched data management features. This enables the reduction of operational inefficiencies and accelerates the transition of data from insights to decisions.

Get Instant Access to the Global Small Molecule Drug Discovery Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

Which Segments Play a Crucial Role in the Expansion of the Small Molecule Drug Discovery Market?

The small molecule drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule Drugs, Biologic Drugs

2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others

3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others

4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization

5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Subsegments:

1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs

2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

What Regions Are Dominating the Small Molecule Drug Discovery Market Growth?

North America was the largest region in the small molecule drug discovery market in 2024. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Characteristics That Define the Small Molecule Drug Discovery Market?

Small Molecule Drug Discovery refers to the process of identifying and developing low molecular weight compounds that can interact with specific biological targets to treat diseases. It is used to create effective medications that can modulate biological pathways, ultimately leading to improved therapeutic outcomes.

Browse Through More Similar Reports By The Business Research Company:

Gastrointestinal Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Metabolic Disorders Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Central Nervous System Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/central-nervous-system-drug-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: